53,215 Shares in iShares Dow Jones US Medical Dev. (IHI) Purchased by Howard Capital Management

Howard Capital Management purchased a new position in shares of iShares Dow Jones US Medical Dev. (BMV:IHI) during the third quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor purchased 53,215 shares of the company’s stock, valued at approximately $12,105,000. iShares Dow Jones US Medical Dev. makes up about 1.6% of Howard Capital Management’s holdings, making the stock its 28th largest holding. Howard Capital Management owned 0.62% of iShares Dow Jones US Medical Dev. as of its most recent filing with the Securities and Exchange Commission (SEC).

A number of other hedge funds and other institutional investors have also recently made changes to their positions in the stock. Migdal Insurance & Financial Holdings Ltd. boosted its holdings in iShares Dow Jones US Medical Dev. by 47.3% during the second quarter. Migdal Insurance & Financial Holdings Ltd. now owns 254,564 shares of the company’s stock worth $51,102,000 after buying an additional 81,770 shares in the last quarter. PFS Investments Inc. raised its position in iShares Dow Jones US Medical Dev. by 26.8% during the third quarter. PFS Investments Inc. now owns 106,057 shares of the company’s stock worth $24,126,000 after acquiring an additional 22,393 shares during the period. SG Americas Securities LLC raised its position in iShares Dow Jones US Medical Dev. by 33.0% during the second quarter. SG Americas Securities LLC now owns 50,000 shares of the company’s stock worth $10,032,000 after acquiring an additional 12,401 shares during the period. Hollencrest Capital Management raised its position in iShares Dow Jones US Medical Dev. by 1.9% during the third quarter. Hollencrest Capital Management now owns 36,023 shares of the company’s stock worth $8,195,000 after acquiring an additional 671 shares during the period. Finally, MinichMacGregor Wealth Management LLC raised its position in iShares Dow Jones US Medical Dev. by 8.5% during the third quarter. MinichMacGregor Wealth Management LLC now owns 32,249 shares of the company’s stock worth $7,343,000 after acquiring an additional 2,533 shares during the period.

BMV:IHI traded down $0.22 during trading hours on Wednesday, reaching $215.80. 880 shares of the company were exchanged, compared to its average volume of 30. iShares Dow Jones US Medical Dev. has a twelve month low of $2,806.59 and a twelve month high of $3,563.30.

The business also recently disclosed a quarterly dividend, which was paid on Tuesday, October 2nd. Shareholders of record on Thursday, September 27th were given a dividend of $0.1046 per share. This represents a $0.42 dividend on an annualized basis and a yield of 0.19%. The ex-dividend date of this dividend was Wednesday, September 26th.

Recommended Story: Compound Annual Growth Rate (CAGR)

Want to see what other hedge funds are holding IHI? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for iShares Dow Jones US Medical Dev. (BMV:IHI).

Institutional Ownership by Quarter for iShares Dow Jones US Medical Dev. (BMV:IHI)

Receive News & Ratings for iShares Dow Jones US Medical Dev. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for iShares Dow Jones US Medical Dev. and related companies with MarketBeat.com's FREE daily email newsletter.

Leave a Reply